Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000151 | ubiquitin ligase complex | 3 | 1 |
GO:0000152 | nuclear ubiquitin ligase complex | 3 | 1 |
GO:0005680 | anaphase-promoting complex | 4 | 1 |
GO:0005737 | cytoplasm | 2 | 1 |
GO:0031461 | cullin-RING ubiquitin ligase complex | 4 | 1 |
GO:0032991 | protein-containing complex | 1 | 1 |
GO:0051286 | cell tip | 3 | 1 |
GO:0060187 | cell pole | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
GO:0140513 | nuclear protein-containing complex | 2 | 1 |
GO:0140535 | intracellular protein-containing complex | 2 | 1 |
GO:1902494 | catalytic complex | 2 | 1 |
GO:1990234 | transferase complex | 3 | 1 |
GO:0016020 | membrane | 2 | 1 |
Related structures:
AlphaFold database: A4HI23
Term | Name | Level | Count |
---|---|---|---|
GO:0006508 | proteolysis | 4 | 1 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 7 | 1 |
GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
GO:0007088 | regulation of mitotic nuclear division | 6 | 1 |
GO:0007091 | metaphase/anaphase transition of mitotic cell cycle | 5 | 1 |
GO:0007346 | regulation of mitotic cell cycle | 5 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0009056 | catabolic process | 2 | 1 |
GO:0009057 | macromolecule catabolic process | 4 | 1 |
GO:0009987 | cellular process | 1 | 3 |
GO:0010498 | proteasomal protein catabolic process | 5 | 1 |
GO:0010564 | regulation of cell cycle process | 5 | 1 |
GO:0010638 | positive regulation of organelle organization | 6 | 1 |
GO:0010965 | regulation of mitotic sister chromatid separation | 6 | 1 |
GO:0016567 | protein ubiquitination | 7 | 1 |
GO:0019538 | protein metabolic process | 3 | 1 |
GO:0019941 | modification-dependent protein catabolic process | 6 | 1 |
GO:0022402 | cell cycle process | 2 | 1 |
GO:0030071 | regulation of mitotic metaphase/anaphase transition | 7 | 1 |
GO:0030163 | protein catabolic process | 4 | 1 |
GO:0031145 | anaphase-promoting complex-dependent catabolic process | 7 | 1 |
GO:0032446 | protein modification by small protein conjugation | 6 | 1 |
GO:0033043 | regulation of organelle organization | 5 | 1 |
GO:0033044 | regulation of chromosome organization | 6 | 1 |
GO:0033045 | regulation of sister chromatid segregation | 5 | 1 |
GO:0036211 | protein modification process | 4 | 1 |
GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process | 6 | 1 |
GO:0043170 | macromolecule metabolic process | 3 | 1 |
GO:0043412 | macromolecule modification | 4 | 1 |
GO:0043632 | modification-dependent macromolecule catabolic process | 5 | 1 |
GO:0044237 | cellular metabolic process | 2 | 1 |
GO:0044238 | primary metabolic process | 2 | 1 |
GO:0044248 | cellular catabolic process | 3 | 1 |
GO:0044260 | obsolete cellular macromolecule metabolic process | 3 | 1 |
GO:0044265 | obsolete cellular macromolecule catabolic process | 4 | 1 |
GO:0044770 | cell cycle phase transition | 3 | 1 |
GO:0044772 | mitotic cell cycle phase transition | 4 | 1 |
GO:0044784 | metaphase/anaphase transition of cell cycle | 4 | 1 |
GO:0045787 | positive regulation of cell cycle | 5 | 1 |
GO:0045840 | positive regulation of mitotic nuclear division | 7 | 1 |
GO:0045842 | positive regulation of mitotic metaphase/anaphase transition | 8 | 1 |
GO:0045931 | positive regulation of mitotic cell cycle | 6 | 1 |
GO:0048518 | positive regulation of biological process | 3 | 1 |
GO:0048522 | positive regulation of cellular process | 4 | 1 |
GO:0050789 | regulation of biological process | 2 | 1 |
GO:0050794 | regulation of cellular process | 3 | 1 |
GO:0051128 | regulation of cellular component organization | 4 | 1 |
GO:0051130 | positive regulation of cellular component organization | 5 | 1 |
GO:0051301 | cell division | 2 | 3 |
GO:0051603 | proteolysis involved in protein catabolic process | 5 | 1 |
GO:0051726 | regulation of cell cycle | 4 | 1 |
GO:0051783 | regulation of nuclear division | 6 | 1 |
GO:0051785 | positive regulation of nuclear division | 7 | 1 |
GO:0051983 | regulation of chromosome segregation | 4 | 1 |
GO:0065007 | biological regulation | 1 | 1 |
GO:0070647 | protein modification by small protein conjugation or removal | 5 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:0090068 | positive regulation of cell cycle process | 6 | 1 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 1 |
GO:1901565 | organonitrogen compound catabolic process | 4 | 1 |
GO:1901575 | organic substance catabolic process | 3 | 1 |
GO:1901970 | positive regulation of mitotic sister chromatid separation | 7 | 1 |
GO:1901987 | regulation of cell cycle phase transition | 6 | 1 |
GO:1901989 | positive regulation of cell cycle phase transition | 7 | 1 |
GO:1901990 | regulation of mitotic cell cycle phase transition | 6 | 1 |
GO:1901992 | positive regulation of mitotic cell cycle phase transition | 7 | 1 |
GO:1902099 | regulation of metaphase/anaphase transition of cell cycle | 6 | 1 |
GO:1902101 | positive regulation of metaphase/anaphase transition of cell cycle | 7 | 1 |
GO:1903047 | mitotic cell cycle process | 3 | 1 |
GO:1905818 | regulation of chromosome separation | 5 | 1 |
GO:1905820 | positive regulation of chromosome separation | 6 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 159 | 163 | PF00656 | 0.236 |
CLV_C14_Caspase3-7 | 522 | 526 | PF00656 | 0.673 |
CLV_NRD_NRD_1 | 322 | 324 | PF00675 | 0.310 |
CLV_NRD_NRD_1 | 359 | 361 | PF00675 | 0.392 |
CLV_NRD_NRD_1 | 417 | 419 | PF00675 | 0.245 |
CLV_NRD_NRD_1 | 481 | 483 | PF00675 | 0.468 |
CLV_NRD_NRD_1 | 517 | 519 | PF00675 | 0.568 |
CLV_PCSK_KEX2_1 | 322 | 324 | PF00082 | 0.310 |
CLV_PCSK_KEX2_1 | 481 | 483 | PF00082 | 0.456 |
CLV_PCSK_KEX2_1 | 517 | 519 | PF00082 | 0.570 |
CLV_PCSK_PC7_1 | 477 | 483 | PF00082 | 0.465 |
CLV_PCSK_SKI1_1 | 130 | 134 | PF00082 | 0.386 |
CLV_PCSK_SKI1_1 | 149 | 153 | PF00082 | 0.178 |
CLV_PCSK_SKI1_1 | 213 | 217 | PF00082 | 0.500 |
CLV_PCSK_SKI1_1 | 352 | 356 | PF00082 | 0.449 |
CLV_PCSK_SKI1_1 | 383 | 387 | PF00082 | 0.397 |
CLV_PCSK_SKI1_1 | 41 | 45 | PF00082 | 0.428 |
CLV_PCSK_SKI1_1 | 477 | 481 | PF00082 | 0.325 |
CLV_PCSK_SKI1_1 | 59 | 63 | PF00082 | 0.299 |
CLV_PCSK_SKI1_1 | 80 | 84 | PF00082 | 0.387 |
DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.475 |
DOC_CYCLIN_RxL_1 | 146 | 156 | PF00134 | 0.323 |
DOC_CYCLIN_RxL_1 | 477 | 487 | PF00134 | 0.471 |
DOC_CYCLIN_yClb5_NLxxxL_5 | 209 | 216 | PF00134 | 0.248 |
DOC_MAPK_gen_1 | 258 | 267 | PF00069 | 0.411 |
DOC_MAPK_gen_1 | 481 | 488 | PF00069 | 0.481 |
DOC_MAPK_MEF2A_6 | 165 | 172 | PF00069 | 0.278 |
DOC_MAPK_MEF2A_6 | 230 | 239 | PF00069 | 0.274 |
DOC_MAPK_MEF2A_6 | 481 | 488 | PF00069 | 0.481 |
DOC_MAPK_NFAT4_5 | 230 | 238 | PF00069 | 0.419 |
DOC_MAPK_NFAT4_5 | 481 | 489 | PF00069 | 0.488 |
DOC_PP1_RVXF_1 | 122 | 129 | PF00149 | 0.454 |
DOC_PP1_RVXF_1 | 491 | 497 | PF00149 | 0.555 |
DOC_PP1_RVXF_1 | 537 | 544 | PF00149 | 0.701 |
DOC_PP2B_LxvP_1 | 164 | 167 | PF13499 | 0.340 |
DOC_PP2B_PxIxI_1 | 167 | 173 | PF00149 | 0.277 |
DOC_USP7_MATH_1 | 101 | 105 | PF00917 | 0.518 |
DOC_USP7_MATH_1 | 363 | 367 | PF00917 | 0.235 |
DOC_USP7_MATH_1 | 392 | 396 | PF00917 | 0.279 |
DOC_USP7_MATH_1 | 438 | 442 | PF00917 | 0.359 |
DOC_USP7_MATH_1 | 501 | 505 | PF00917 | 0.433 |
DOC_WW_Pin1_4 | 243 | 248 | PF00397 | 0.463 |
DOC_WW_Pin1_4 | 503 | 508 | PF00397 | 0.503 |
DOC_WW_Pin1_4 | 529 | 534 | PF00397 | 0.568 |
LIG_14-3-3_CanoR_1 | 174 | 178 | PF00244 | 0.320 |
LIG_14-3-3_CanoR_1 | 213 | 219 | PF00244 | 0.478 |
LIG_14-3-3_CanoR_1 | 230 | 234 | PF00244 | 0.467 |
LIG_14-3-3_CanoR_1 | 289 | 297 | PF00244 | 0.317 |
LIG_14-3-3_CanoR_1 | 437 | 447 | PF00244 | 0.343 |
LIG_14-3-3_CanoR_1 | 491 | 497 | PF00244 | 0.619 |
LIG_14-3-3_CanoR_1 | 500 | 506 | PF00244 | 0.660 |
LIG_Actin_WH2_2 | 44 | 61 | PF00022 | 0.383 |
LIG_AP2alpha_2 | 136 | 138 | PF02296 | 0.347 |
LIG_BRCT_BRCA1_1 | 539 | 543 | PF00533 | 0.562 |
LIG_BRCT_BRCA1_1 | 71 | 75 | PF00533 | 0.483 |
LIG_FHA_1 | 185 | 191 | PF00498 | 0.493 |
LIG_FHA_1 | 194 | 200 | PF00498 | 0.464 |
LIG_FHA_1 | 217 | 223 | PF00498 | 0.332 |
LIG_FHA_1 | 230 | 236 | PF00498 | 0.352 |
LIG_FHA_1 | 244 | 250 | PF00498 | 0.264 |
LIG_FHA_1 | 448 | 454 | PF00498 | 0.376 |
LIG_FHA_2 | 522 | 528 | PF00498 | 0.673 |
LIG_LIR_Gen_1 | 141 | 151 | PF02991 | 0.372 |
LIG_LIR_Gen_1 | 153 | 161 | PF02991 | 0.264 |
LIG_LIR_Gen_1 | 499 | 510 | PF02991 | 0.401 |
LIG_LIR_Gen_1 | 511 | 519 | PF02991 | 0.355 |
LIG_LIR_Gen_1 | 53 | 61 | PF02991 | 0.492 |
LIG_LIR_Nem_3 | 141 | 146 | PF02991 | 0.364 |
LIG_LIR_Nem_3 | 153 | 158 | PF02991 | 0.268 |
LIG_LIR_Nem_3 | 299 | 304 | PF02991 | 0.312 |
LIG_LIR_Nem_3 | 415 | 420 | PF02991 | 0.278 |
LIG_LIR_Nem_3 | 428 | 433 | PF02991 | 0.197 |
LIG_LIR_Nem_3 | 499 | 505 | PF02991 | 0.435 |
LIG_LIR_Nem_3 | 509 | 515 | PF02991 | 0.447 |
LIG_LIR_Nem_3 | 53 | 57 | PF02991 | 0.488 |
LIG_NBox_RRM_1 | 75 | 85 | PF00076 | 0.366 |
LIG_Pex14_2 | 297 | 301 | PF04695 | 0.270 |
LIG_SH2_CRK | 342 | 346 | PF00017 | 0.328 |
LIG_SH2_CRK | 393 | 397 | PF00017 | 0.260 |
LIG_SH2_CRK | 417 | 421 | PF00017 | 0.338 |
LIG_SH2_GRB2like | 429 | 432 | PF00017 | 0.321 |
LIG_SH2_NCK_1 | 280 | 284 | PF00017 | 0.294 |
LIG_SH2_NCK_1 | 342 | 346 | PF00017 | 0.490 |
LIG_SH2_SRC | 268 | 271 | PF00017 | 0.323 |
LIG_SH2_STAP1 | 262 | 266 | PF00017 | 0.434 |
LIG_SH2_STAP1 | 423 | 427 | PF00017 | 0.266 |
LIG_SH2_STAT3 | 228 | 231 | PF00017 | 0.381 |
LIG_SH2_STAT3 | 429 | 432 | PF00017 | 0.388 |
LIG_SH2_STAT5 | 185 | 188 | PF00017 | 0.493 |
LIG_SH2_STAT5 | 262 | 265 | PF00017 | 0.390 |
LIG_SH2_STAT5 | 286 | 289 | PF00017 | 0.448 |
LIG_SH2_STAT5 | 296 | 299 | PF00017 | 0.374 |
LIG_SH2_STAT5 | 337 | 340 | PF00017 | 0.333 |
LIG_SH2_STAT5 | 433 | 436 | PF00017 | 0.251 |
LIG_SUMO_SIM_anti_2 | 156 | 163 | PF11976 | 0.230 |
LIG_SUMO_SIM_anti_2 | 196 | 201 | PF11976 | 0.383 |
LIG_SUMO_SIM_par_1 | 156 | 163 | PF11976 | 0.230 |
LIG_SUMO_SIM_par_1 | 373 | 380 | PF11976 | 0.259 |
LIG_TYR_ITAM | 259 | 277 | PF00017 | 0.435 |
LIG_WRC_WIRS_1 | 502 | 507 | PF05994 | 0.414 |
MOD_CK1_1 | 144 | 150 | PF00069 | 0.453 |
MOD_CK1_1 | 188 | 194 | PF00069 | 0.423 |
MOD_CK1_1 | 217 | 223 | PF00069 | 0.371 |
MOD_CK1_1 | 243 | 249 | PF00069 | 0.406 |
MOD_CK1_1 | 288 | 294 | PF00069 | 0.390 |
MOD_CK1_1 | 403 | 409 | PF00069 | 0.321 |
MOD_CK1_1 | 495 | 501 | PF00069 | 0.665 |
MOD_CK1_1 | 503 | 509 | PF00069 | 0.591 |
MOD_CK1_1 | 511 | 517 | PF00069 | 0.448 |
MOD_CK1_1 | 521 | 527 | PF00069 | 0.582 |
MOD_CK2_1 | 275 | 281 | PF00069 | 0.319 |
MOD_CK2_1 | 503 | 509 | PF00069 | 0.551 |
MOD_GlcNHglycan | 117 | 121 | PF01048 | 0.344 |
MOD_GlcNHglycan | 143 | 146 | PF01048 | 0.346 |
MOD_GlcNHglycan | 15 | 18 | PF01048 | 0.469 |
MOD_GlcNHglycan | 187 | 190 | PF01048 | 0.344 |
MOD_GlcNHglycan | 21 | 24 | PF01048 | 0.407 |
MOD_GlcNHglycan | 453 | 456 | PF01048 | 0.361 |
MOD_GSK3_1 | 184 | 191 | PF00069 | 0.548 |
MOD_GSK3_1 | 329 | 336 | PF00069 | 0.276 |
MOD_GSK3_1 | 447 | 454 | PF00069 | 0.310 |
MOD_GSK3_1 | 459 | 466 | PF00069 | 0.320 |
MOD_GSK3_1 | 521 | 528 | PF00069 | 0.554 |
MOD_GSK3_1 | 529 | 536 | PF00069 | 0.501 |
MOD_N-GLC_1 | 39 | 44 | PF02516 | 0.401 |
MOD_N-GLC_1 | 438 | 443 | PF02516 | 0.412 |
MOD_N-GLC_2 | 259 | 261 | PF02516 | 0.495 |
MOD_NEK2_1 | 160 | 165 | PF00069 | 0.343 |
MOD_NEK2_1 | 240 | 245 | PF00069 | 0.331 |
MOD_NEK2_1 | 273 | 278 | PF00069 | 0.330 |
MOD_NEK2_1 | 340 | 345 | PF00069 | 0.327 |
MOD_NEK2_1 | 355 | 360 | PF00069 | 0.342 |
MOD_NEK2_1 | 447 | 452 | PF00069 | 0.245 |
MOD_NEK2_2 | 173 | 178 | PF00069 | 0.450 |
MOD_NEK2_2 | 459 | 464 | PF00069 | 0.308 |
MOD_PKA_2 | 173 | 179 | PF00069 | 0.337 |
MOD_PKA_2 | 229 | 235 | PF00069 | 0.404 |
MOD_PKA_2 | 288 | 294 | PF00069 | 0.317 |
MOD_PKA_2 | 492 | 498 | PF00069 | 0.624 |
MOD_PKB_1 | 518 | 526 | PF00069 | 0.598 |
MOD_Plk_1 | 355 | 361 | PF00069 | 0.450 |
MOD_Plk_1 | 39 | 45 | PF00069 | 0.395 |
MOD_Plk_1 | 508 | 514 | PF00069 | 0.424 |
MOD_Plk_4 | 333 | 339 | PF00069 | 0.296 |
MOD_Plk_4 | 363 | 369 | PF00069 | 0.300 |
MOD_Plk_4 | 412 | 418 | PF00069 | 0.307 |
MOD_Plk_4 | 53 | 59 | PF00069 | 0.422 |
MOD_Plk_4 | 94 | 100 | PF00069 | 0.423 |
MOD_ProDKin_1 | 243 | 249 | PF00069 | 0.455 |
MOD_ProDKin_1 | 503 | 509 | PF00069 | 0.499 |
MOD_ProDKin_1 | 529 | 535 | PF00069 | 0.567 |
MOD_SUMO_for_1 | 203 | 206 | PF00179 | 0.461 |
MOD_SUMO_for_1 | 309 | 312 | PF00179 | 0.305 |
MOD_SUMO_rev_2 | 84 | 90 | PF00179 | 0.424 |
TRG_DiLeu_BaEn_1 | 156 | 161 | PF01217 | 0.448 |
TRG_DiLeu_BaEn_2 | 250 | 256 | PF01217 | 0.448 |
TRG_DiLeu_BaLyEn_6 | 244 | 249 | PF01217 | 0.387 |
TRG_ENDOCYTIC_2 | 262 | 265 | PF00928 | 0.441 |
TRG_ENDOCYTIC_2 | 274 | 277 | PF00928 | 0.437 |
TRG_ENDOCYTIC_2 | 308 | 311 | PF00928 | 0.329 |
TRG_ENDOCYTIC_2 | 337 | 340 | PF00928 | 0.300 |
TRG_ENDOCYTIC_2 | 342 | 345 | PF00928 | 0.301 |
TRG_ENDOCYTIC_2 | 393 | 396 | PF00928 | 0.260 |
TRG_ENDOCYTIC_2 | 417 | 420 | PF00928 | 0.338 |
TRG_ENDOCYTIC_2 | 502 | 505 | PF00928 | 0.430 |
TRG_ER_diArg_1 | 321 | 323 | PF00400 | 0.313 |
TRG_ER_diArg_1 | 434 | 437 | PF00400 | 0.351 |
TRG_ER_diArg_1 | 480 | 482 | PF00400 | 0.473 |
TRG_ER_diArg_1 | 490 | 493 | PF00400 | 0.610 |
TRG_ER_diArg_1 | 517 | 520 | PF00400 | 0.578 |
TRG_NES_CRM1_1 | 156 | 169 | PF08389 | 0.342 |
TRG_NES_CRM1_1 | 19 | 32 | PF08389 | 0.401 |
TRG_NES_CRM1_1 | 50 | 63 | PF08389 | 0.372 |
TRG_NES_CRM1_1 | 87 | 102 | PF08389 | 0.398 |
TRG_Pf-PMV_PEXEL_1 | 149 | 153 | PF00026 | 0.364 |
TRG_Pf-PMV_PEXEL_1 | 418 | 422 | PF00026 | 0.218 |
TRG_Pf-PMV_PEXEL_1 | 46 | 50 | PF00026 | 0.378 |
TRG_Pf-PMV_PEXEL_1 | 482 | 487 | PF00026 | 0.329 |
TRG_Pf-PMV_PEXEL_1 | 517 | 522 | PF00026 | 0.401 |
TRG_Pf-PMV_PEXEL_1 | 539 | 544 | PF00026 | 0.638 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IM16 | Leptomonas seymouri | 78% | 100% |
A0A0S4J8L2 | Bodo saltans | 39% | 76% |
A0A1X0P255 | Trypanosomatidae | 54% | 100% |
A0A3S5H7M5 | Leishmania donovani | 93% | 100% |
A0A422NIF3 | Trypanosoma rangeli | 55% | 100% |
A4I5A0 | Leishmania infantum | 93% | 100% |
B3DNN5 | Arabidopsis thaliana | 34% | 100% |
C9ZQN1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 52% | 91% |
E9B0J6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 92% | 100% |
P41889 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 30% | 81% |
Q13042 | Homo sapiens | 29% | 88% |
Q4Q7N6 | Leishmania major | 92% | 100% |
Q8R349 | Mus musculus | 30% | 88% |
V5AS70 | Trypanosoma cruzi | 54% | 100% |